BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 35443541)

  • 21. Concomitant EGFR mutation and ALK rearrangement in multifocal lung adenocarcinoma: a case report.
    Fan J; Wu J; Huang B; Zhu Y; Shi H; Dai X; Nie X
    Diagn Pathol; 2020 May; 15(1):42. PubMed ID: 32375829
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Incidence and Distribution of Lobe-Specific Mediastinal Lymph Node Metastasis in Non-small Cell Lung Cancer: Data from 4511 Resected Cases.
    Liang RB; Yang J; Zeng TS; Long H; Fu JH; Zhang LJ; Lin P; Wang X; Rong TH; Hou X; Yang HX
    Ann Surg Oncol; 2018 Oct; 25(11):3300-3307. PubMed ID: 30083835
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An epidemiological study of risk factors for lung cancer in Guangzhou, China.
    Du YX; Cha Q; Chen XW; Chen YZ; Huang LF; Feng ZZ; Wu XF; Wu JM
    Lung Cancer; 1996 Mar; 14 Suppl 1():S9-37. PubMed ID: 8785671
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A prospective study of a total material of lung cancer from a county in Sweden 1997-1999: gender, symptoms, type, stage, and smoking habits.
    Koyi H; Hillerdal G; Brandén E
    Lung Cancer; 2002 Apr; 36(1):9-14. PubMed ID: 11891027
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Driver genes as predictive indicators of brain metastasis in patients with advanced NSCLC: EGFR, ALK, and RET gene mutations.
    Wang H; Wang Z; Zhang G; Zhang M; Zhang X; Li H; Zheng X; Ma Z
    Cancer Med; 2020 Jan; 9(2):487-495. PubMed ID: 31769228
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Imaging Characteristics of Driver Mutations in EGFR, KRAS, and ALK among Treatment-Naïve Patients with Advanced Lung Adenocarcinoma.
    Park J; Kobayashi Y; Urayama KY; Yamaura H; Yatabe Y; Hida T
    PLoS One; 2016; 11(8):e0161081. PubMed ID: 27518729
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lung Cancer in Bahrain: Histological and Molecular Features.
    Mubarak A; Aljufairi E; Almahari SA
    Gulf J Oncolog; 2020 Sep; 1(34):48-51. PubMed ID: 33431362
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Liver metastasis predicts poorer prognosis in stage IV lung adenocarcinoma patients receiving first-line gefitinib.
    Wu KL; Tsai MJ; Yang CJ; Chang WA; Hung JY; Yen CJ; Shen CH; Kuo TY; Lee JY; Chou SH; Liu TC; Chong IW; Huang MS
    Lung Cancer; 2015 May; 88(2):187-94. PubMed ID: 25747806
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Next generation sequencing in lung cancer: An initial experience from India.
    Gupta P; Saha K; Vinarkar S; Banerjee S; Choudhury SS; Parihar M; Midha D; Mukherjee G; Lingegowda D; Chatterjee S; ArunsinghS M; Shrimali R; Ganguly S; Dabkara D; Biswas B; Mishra DK; Arora N
    Curr Probl Cancer; 2020 Jun; 44(3):100562. PubMed ID: 32178863
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A 10-year retrospective study of lung cancer in Uganda.
    Bogere N; Bongomin F; Katende A; Omaido BA; Namukwaya E; Mayanja-Kizza H; Walusansa V
    BMC Cancer; 2022 Feb; 22(1):204. PubMed ID: 35197014
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison study of clinicoradiological profile of primary lung cancer cases: an Eastern India experience.
    Dey A; Biswas D; Saha SK; Kundu S; Kundu S; Sengupta A
    Indian J Cancer; 2012; 49(1):89-95. PubMed ID: 22842174
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinicopathologic Characteristics, Treatment Outcomes, and Acquired Resistance Patterns of Atypical EGFR Mutations and HER2 Alterations in Stage IV Non-Small-Cell Lung Cancer.
    Patil T; Mushtaq R; Marsh S; Azelby C; Pujara M; Davies KD; Aisner DL; Purcell WT; Schenk EL; Pacheco JM; Bunn PA; Camidge DR; Doebele RC
    Clin Lung Cancer; 2020 May; 21(3):e191-e204. PubMed ID: 31859066
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lung cancer in Maharaj Nakorn Chiang Mai Hospital: comparison of the clinical manifestations between the young and old age groups.
    Deesomchok A; Dechayonbancha N; Thongprasert S
    J Med Assoc Thai; 2005 Sep; 88(9):1236-41. PubMed ID: 16536110
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The spread of metastatic lymph nodes to the mediastinum from left upper lobe cancer: results of superior mediastinal nodal dissection through a median sternotomy.
    Sakao Y; Miyamoto H; Yamazaki A; Ou S; Shiomi K; Sonobe S; Sakuraba M
    Eur J Cardiothorac Surg; 2006 Sep; 30(3):543-7. PubMed ID: 16870462
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular Adequacy of Image-Guided Rebiopsies for Molecular Retesting in Advanced Non-Small Cell Lung Cancer: A Single-Center Experience.
    Tokaca N; Barth S; O'Brien M; Bhosle J; Fotiadis N; Wotherspoon A; Thompson L; Popat S
    J Thorac Oncol; 2018 Jan; 13(1):63-72. PubMed ID: 28989040
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epidermal growth factor receptor mutation status in pulmonary adenocarcinoma: Multi-institutional data discussion at national conference of "Lung Cancer Management in Indian context".
    Nakra T; Mehta A; Bal A; Nambirajan A; Mishra D; Midha D; Gupta N; Arora N; Gupta P; Gupta P; Singh V; Jain D
    Curr Probl Cancer; 2020 Jun; 44(3):100561. PubMed ID: 32169258
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Features and prognostic impact of distant metastasis in patients with stage IV lung adenocarcinoma harboring EGFR mutations: importance of bone metastasis.
    Fujimoto D; Ueda H; Shimizu R; Kato R; Otoshi T; Kawamura T; Tamai K; Shibata Y; Matsumoto T; Nagata K; Otsuka K; Nakagawa A; Otsuka K; Katakami N; Tomii K
    Clin Exp Metastasis; 2014 Jun; 31(5):543-51. PubMed ID: 24682604
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The clinicopathological significance of ALK rearrangements and KRAS and EGFR mutations in primary pulmonary mucinous adenocarcinoma.
    Qu Y; Che N; Zhao D; Zhang C; Su D; Zhou L; Zhang L; Wang C; Zhang H; Wei L
    Tumour Biol; 2015 Aug; 36(8):6417-24. PubMed ID: 25813151
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Poor prognosis of NSCLC located in lower lobe is partly mediated by lower frequency of EGFR mutations.
    Lee HW; Park YS; Park S; Lee CH
    Sci Rep; 2020 Sep; 10(1):14933. PubMed ID: 32913267
    [TBL] [Abstract][Full Text] [Related]  

  • 40. EGFR, KRAS, BRAF, ALK, and cMET genetic alterations in 1440 Sardinian patients with lung adenocarcinoma.
    Colombino M; Paliogiannis P; Cossu A; Santeufemia DA; ; Sini MC; Casula M; Palomba G; Manca A; Pisano M; Doneddu V; Palmieri G
    BMC Pulm Med; 2019 Nov; 19(1):209. PubMed ID: 31711449
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.